Ghent University Academic Bibliography

Your filters: cql: author="Antoniou, Antonis C." or (type any "bookEditor issueEditor" and editor="Antoniou, Antonis...

Add to list
- Journal Article
- A1
- open access
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

Denise G. O’Mahony, Susan J. Ramus, Melissa C. Southey, Nicola S. Meagher, Andreas Hadjisavvas, Esther M. John, Ute Hamann, Evgeny N. Imyanitov, Irene L. Andrulis, Priyanka Sharma, et al.

(2023) BRITISH JOURNAL OF CANCER. 128(12). p.2283-2294
Add to list
- Journal Article
- A1
- open access
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

Christopher Hakkaart, John F. Pearson, Louise Marquart, Joe Dennis, George A. R. Wiggins, Daniel R. Barnes, Bridget A. Robinson, Peter D. Mace, Kristiina Aittomäki, Irene L. Andrulis, et al.

(2022) COMMUNICATIONS BIOLOGY. 5(1).
Add to list
- Journal Article
- A1
- open access
Polygenic risk modeling for prediction of epithelial ovarian cancer risk

Eileen O. Dareng, Jonathan P. Tyrer, Daniel R. Barnes, Michelle R. Jones, Xin Yang, Katja K. H. Aben, Muriel A. Adank, Simona Agata, Irene L. Andrulis, Hoda Anton-Culver, et al.

(2022) EUROPEAN JOURNAL OF HUMAN GENETICS. 30(3). p.349-362
Add to list
- Journal Article
- A1
- open access
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

Inge M. M. Lakeman, Alexandra J. van den Broek, Julien A. M. Vos, Daniel R. Barnes, Julian Adlard, Irene L. Andrulis, Adalgeir Arason, Norbert Arnold, Banu K. Arun, Judith Balmana, et al.

(2021) GENETICS IN MEDICINE. 23(9). p.1726-1737
Add to list
- Journal Article
- A1
- open access
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Juliette Coignard, Michael Lush, Jonathan Beesley, Tracy A. O'Mara, Joe Dennis, Jonathan P. Tyrer, Daniel R. Barnes, Lesley McGuffog, Goska Leslie, Manjeet K. Bolla, et al.

(2021) NATURE COMMUNICATIONS. 12(1).
Add to list
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M. Dunning, James Redman, James Scarth, Inga Plaskocinska, et al.

(2020) Journal of Clinical Oncology. 38(7). p.674-687
Add to list
Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants : results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Valentina Silvestri, Goska Leslie, Daniel R. Barnes, Bjarni A. Agnarsson, Kristiina Aittomäki, Elisa Alducci, Irene L. Andrulis, Rosa B. Barkardottir, Alicia Barroso, Daniel Barrowdale, et al.

(2020) JAMA ONCOLOGY. 6(8). p.1218-1230
Add to list
- Journal Article
- A1
- open access
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Daniel R. Barnes, Matti A. Rookus, Lesley McGuffog, Goska Leslie, Thea M. Mooij, Joe Dennis, Nasim Mavaddat, Julian Adlard, Munaza Ahmed, Kristiina Aittomäki, et al.

(2020) GENETICS IN MEDICINE. 22(10). p.1653-1666
Add to list
- Journal Article
- A1
- open access
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

Helian Feng, Alexander Gusev, Bogdan Pasaniuc, Lang Wu, Jirong Long, Zomoroda Abu-full, Kristiina Aittomaki, Irene L. Andrulis, Hoda Anton-Culver, Antonis C. Antoniou, et al.

(2020) GENETIC EPIDEMIOLOGY. 44(5). p.442-468
Add to list
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness

Vivek L. Patel, Evan L. Busch, Tara M. Friebel, Angel Cronin, Goska Leslie, Lesley McGuffog, Julian Adlard, Simona Agata, Bjarni A. Agnarsson, Munaza Ahmed, et al.

(2020) CANCER RESEARCH. 80(3). p.624-638

Academic Bibliography

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

Polygenic risk modeling for prediction of epithelial ovarian cancer risk

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

Characterization of the cancer spectrum in men with germline BRCA1 and BRCA2 pathogenic variants : results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness

Contents

Support

Contact